Drawing for Serial No. 87697882

USPTO serial 87697882

Serial No. 87697882

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GALBO, AMANDA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 87697882?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Camille M. Miller

Camille M. Miller COZEN O'CONNOR1650 MARKET STREET, Suite 2800One Liberty PlacePHILADELPHIA, PA 19103

Goods and services

ClassDescriptionStatusFirst use
042Providing medical and scientific research information in the field of pharmaceuticals and certain diseasesACTIVE—
044Support services, namely, providing healthcare and wellness information to individuals with a life-changing or life-threatening disease to help these individuals take an active role in their healthcare and help others with their diseases; programs in the nature of providing medical counseling and medical information in the field of pharmaceuticals and safety issues pertaining to pharmaceuticals, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; providing a web site featuring medical information; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing pharmaceutical advice; providing medical information, consultancy and advisory servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 19, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 18, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 15, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 13, 2020EX4GSOU EXTENSION 4 GRANTED—
May 13, 2020EXT4SOU EXTENSION 4 FILED—
May 13, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 9, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 7, 2019EX3GSOU EXTENSION 3 GRANTED—
Oct 7, 2019EXT3SOU EXTENSION 3 FILED—
Oct 7, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 16, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 12, 2019EX2GSOU EXTENSION 2 GRANTED—
Apr 12, 2019EXT2SOU EXTENSION 2 FILED—
Apr 12, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 9, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 7, 2018EX1GSOU EXTENSION 1 GRANTED—
Nov 7, 2018EXT1SOU EXTENSION 1 FILED—
Nov 7, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 12, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 17, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 17, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 28, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 15, 2018ALIEASSIGNED TO LIE—
Mar 5, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 5, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Mar 5, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 5, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 5, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 28, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Feb 28, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 28, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 28, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 23, 2018DOCKASSIGNED TO EXAMINER—
Dec 7, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Dec 6, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 30, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance